(Q37996960)

26 August 2017

title

Dynamic proteome in enigmatic preeclampsia: an account of molecular mechanisms and biomarker discovery (English)

1 reference

26 August 2017

0 references

0 references

0 references

Sheon Mary

1

1 reference

26 August 2017

Gouri V Patil

2

1 reference

26 August 2017

Asmita V Kulkarni

3

1 reference

26 August 2017

Mahesh J Kulkarni

4

1 reference

26 August 2017

Sadhana R Joshi

5

1 reference

26 August 2017

Savita S Mehendale

6

1 reference

26 August 2017

Ashok P Giri

7

1 reference

26 August 2017

publication date

1 January 2012

1 reference

Proteomics - Clinical Applications

26 August 2017

published in

1 reference

26 August 2017

volume

6

1 reference

26 August 2017

issue

1-2

1 reference

26 August 2017

page(s)

79-90

1 reference

Failure of physiologic transformation of the spiral arteries in patients with preterm labor and intact membranes

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201100089

First-trimester placentation and the risk of antepartum stillbirth

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201100089

Increased endothelial monocyte chemoattractant protein-1 and interleukin-8 in preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201100089

Prediction and prevention of recurrent preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201100089

Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201100089

Partner change and perinatal outcomes: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201100089

Preterm birth: a review of genetic factors and future directions for genetic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201100089

Preeclampsia--a pressing problem: an executive summary of a National Institute of Child Health and Human Development workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201100089

Pathophysiology of hypertension during preeclampsia: linking placental ischemia with endothelial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201100089

Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype. One cause of defective endovascular invasion in this syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201100089

Endothelial dysfunction in preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201100089

Biological consequences of tumor hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201100089

Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes. Flt-1, but not Flk-1/KDR, is up-regulated by hypoxia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201100089

Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201100089

Hypoxia and sFlt-1 in preeclampsia: the "chicken-and-egg" question

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201100089

Oxygen, the Janus gas; its effects on human placental development and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201100089

IFPA Award in Placentology Lecture: Complicated interactions between genes and the environment in placentation, pregnancy outcome and long term health

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201100089

Trophoblast deportation and the maternal inflammatory response in pre-eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201100089

Reduced selenium concentrations and glutathione peroxidase activity in preeclamptic pregnancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201100089

Latest advances in understanding preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201100089

Placental superoxide is increased in pre-eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201100089

Placental isoprostane is significantly increased in preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201100089

Fatty acids, antioxidants, and oxidative stress in pre-eclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201100089

Vasculogenesis, angiogenesis, and growth factors: ephrins enter the fray at the border

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201100089

Preeclampsia and angiogenic imbalance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201100089

Angiogenic growth factor levels in maternal and fetal blood: correlation with Doppler ultrasound parameters in pregnancies complicated by pre-eclampsia and intrauterine growth restriction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201100089

Novel soluble Flt-1 isoforms in plasma and cultured placental explants from normotensive pregnant and preeclamptic women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201100089

Relationships between TGFbeta proteins and oxygen concentrations inside the first trimester human gestational sac

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201100089

Reduced placental docosahexaenoic acid levels associated with increased levels of sFlt-1 in preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201100089

Placental growth factor and soluble FMS-like tyrosine kinase-1 in early-onset and late-onset preeclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201100089

Soluble endoglin and other circulating antiangiogenic factors in preeclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201100089

Angiogenin and vascular endothelial growth factor in pregnancies complicated by preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201100089

Endoglin, PlGF and sFlt-1 as markers for predicting pre-eclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201100089

Circulating angiogenic factors and their association with birth outcomes in preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201100089

Circulating angiogenic factors and the risk of preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201100089

The influence of donated gametes on the incidence of hypertensive disorders of pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201100089

Placental cytokines and preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201100089

How Does the maternal immune system contribute to the development of pre-eclampsia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201100089

Angiogenic factors and natural killer (NK) cells in the pathogenesis of preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201100089

Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201100089

Innate immune response by ficolin binding in apoptotic placenta is associated with the clinical syndrome of preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201100089

Increased chymotrypsin-like protease (chymase) expression and activity in placentas from women with preeclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201100089

AT1 receptor heterodimers and angiotensin II responsiveness in preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201100089

Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201100089

AT1 receptor agonistic antibodies from preeclamptic patients stimulate NADPH oxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201100089

The functional role of the renin-angiotensin system in pregnancy and preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201100089

Autoantibody from women with preeclampsia induces soluble Fms-like tyrosine kinase-1 production via angiotensin type 1 receptor and calcineurin/nuclear factor of activated T-cells signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201100089

Searching for genetic clues to the causes of pre-eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201100089

STOX1: Key player in trophoblast dysfunction underlying early onset preeclampsia with growth retardation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201100089

Epigenetic control of fetal gene expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201100089

Gene expression patterns in human placenta

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201100089

Differential placental gene expression in severe preeclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201100089

Is epigenetics an important link between early life events and adult disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201100089

Association of omega-3 fatty acids and homocysteine concentrations in pre-eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201100089

Gestation-dependent changes in human placental global DNA methylation levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201100089

Proteomic analysis of human reproductive fluids

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201100089

Amniotic fluid: not just fetal urine anymore

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201100089

The proteomic analysis of human neonatal umbilical cord serum by mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201100089

How useful is uterine artery Doppler flow velocimetry in the prediction of pre-eclampsia, intrauterine growth retardation and perinatal death? An overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201100089

Accuracy of urine dipsticks, 2-h and 12-h urine collections for protein measurement as compared with the 24-h collection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201100089

Estimation of proteinuria as a predictor of complications of pre-eclampsia: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201100089

Proteomic profiling of urine identifies specific fragments of SERPINA1 and albumin as biomarkers of preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201100089

The serpins are an expanding superfamily of structurally similar but functionally diverse proteins. Evolution, mechanism of inhibition, novel functions, and a revised nomenclature

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201100089

Expressional and epigenetic alterations of placental serine protease inhibitors: SERPINA3 is a potential marker of preeclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201100089

A proteomic approach identifies early pregnancy biomarkers for preeclampsia: novel linkages between a predisposition to preeclampsia and cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201100089

Oxidized transthyretin in amniotic fluid as an early marker of preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201100089

Serum profile in preeclampsia and intra-uterine growth restriction revealed by iTRAQ technology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201100089

Urinary proteomics analysis for renal injury in hypertensive disorders of pregnancy with iTRAQ labeling and LC-MS/MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201100089

Aberrant processing of plasma vitronectin and high-molecular-weight kininogen precedes the onset of preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201100089

Urinary proteomics for prediction of preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201100089

Fibrinogen and histidine-rich glycoprotein in early-onset preeclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201100089

Expression of clusterin in normal and preeclamptic placentas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201100089

Proteome analysis reveals elevated serum levels of clusterin in patients with preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201100089

Effective prediction of preeclampsia by a combined ratio of angiogenesis-related factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201100089

Soluble endoglin as a second-trimester marker for preeclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201100089

Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201100089

Soluble endoglin contributes to the pathogenesis of preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201100089

Histidine-rich glycoprotein as an early biomarker of preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201100089

Complement component C4A and apolipoprotein A-I in plasmas as biomarkers of the severe, early-onset preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201100089

Discovery of the serum biomarker proteins in severe preeclampsia by proteomic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201100089

Discriminatory proteomic biomarker analysis identifies free hemoglobin in the cerebrospinal fluid of women with severe preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201100089

Placental growth factor in the cerebrospinal fluid of women with preeclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201100089

Proteomic analysis of human serum for finding pathogenic factors and potential biomarkers in preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201100089

Proteomics of the amniotic fluid in assessment of the placenta. Relevance for preterm birth

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201100089

Proteomic analysis of amniotic fluid to identify women with preterm labor and intra-amniotic inflammation/infection: the use of a novel computational method to analyze mass spectrometric profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201100089

Identification of proteomic biomarkers of preeclampsia in amniotic fluid using SELDI-TOF mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201100089

Toward a better understanding of preeclampsia: Comparative proteomic analysis of preeclamptic placentas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201100089

Proteome differences of placenta between pre-eclampsia and normal pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201100089

Differential proteome analysis of the preeclamptic placenta using optimized protein extraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201100089

A gel-free quantitative proteomics analysis of factors released from hypoxic-conditioned placentae

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201100089

Proteomic analysis of proteins differentially expressed in preeclamptic trophoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201100089

Analysis of expression and comparative profile of normal placental tissue proteins and those in preeclampsia patients using proteomic approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201100089

Functional proteomics: examining the effects of hypoxia on the cytotrophoblast protein repertoire

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201100089

Proteomic analysis of hypoxia-induced responses in the syncytialization of human placental cell line BeWo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201100089

Receptor-activating autoantibodies and disease: preeclampsia and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201100089

SEREX, Proteomex, AMIDA, and beyond: Serological screening technologies for target identification

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201100089

Immunoproteomics: From biomarker discovery to diagnostic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201100089

The receptor for advanced glycation end products (RAGE) is elevated in women with preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201100089

Accumulation of advanced glycation end products in women with preeclampsia: possible involvement of placental oxidative and nitrative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201100089

Elucidation of the molecular mechanisms of preeclampsia using proteomic technologies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201100089

Analysis of nitroso-proteomes in normotensive and severe preeclamptic human placentas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201100089

An altered pattern of circulating apolipoprotein E3 isoforms is implicated in preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201100089

Proteomic analysis reveals an elevated expression of heat shock protein 27 in preeclamptic placentas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201100089

Autocrine activity of soluble Flt-1 controls endothelial cell function and angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201100089

Insulin resistance in human preeclamptic placenta is mediated by serine phosphorylation of insulin receptor substrate-1 and -2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201100089

A proof-of-principle gel-free proteomics strategy for the identification of predictive biomarkers for the onset of pre-eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201100089

A sister's risk: Family history as a predictor of preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201100089

Proteomics Analysis of Human Amniotic Fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201100089

Use of proteomic patterns as a novel screening tool in pre-eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201100089

Failure of physiologic transformation of the spiral arteries in the placental bed in preterm premature rupture of membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201100089

21 January 2018

Identifiers

DOI

10.1002/PRCA.201100089

1 reference

26 August 2017

1 reference